IMVT
#1041
Immunovant, Inc. - Common Stock
38.7 0 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.54%
Monthly Change
+14.50%
6 month change
+41.60%
Year Change
+101.46%
Previous Close
39.7 1
Open
38.7 0
Low
38.7 0
High
38.7 0
Volume
131
Financials
- Market Capitalization 7.95 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.97
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1025 |  IBRX ImmunityBio, Inc. - Common Stock | 7.79 USD | -5.23% | -13.06% | +7.45% | +166.78% | 8.16 B USD | ||
| 1026 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 93.73 USD | -4.10% | +5.46% | +14.91% | +292.01% | 8.14 B USD | ||
| 1065 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 60.94 USD | -3.94% | -3.73% | +17.76% | +53.71% | 7.62 B USD | ||
| 1081 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.49 USD | -0.84% | -4.88% | +15.58% | -2.56% | 7.37 B USD |
Frequently asked questions about Immunovant, Inc. - Common Stock
What is the Immunovant, Inc. - Common Stock stock price today?
The current price of Immunovant, Inc. - Common Stock (IMVT) is 38.7. Over the past 24 hours, the stock has changed by -2.54%. Follow the IMVT chart for real-time price dynamics.
What is the stock ticker of Immunovant, Inc. - Common Stock?
Immunovant, Inc. - Common Stock trades under the ticker IMVT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunovant, Inc. - Common Stock stock going up?
IMVT has changed by -0.77% over the last week, +14.50% over the last month, and +101.46% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immunovant, Inc. - Common Stock net income for the last quarter?
Immunovant, Inc. - Common Stock reported net income of -147.86 M for the last quarter. The previous quarter showed -110.64 M, which means net income changed by -33.64%.
How many employees does Immunovant, Inc. - Common Stock have?
As of the latest available data, Immunovant, Inc. - Common Stock has 315 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immunovant, Inc. - Common Stock stock?
You can buy Immunovant, Inc. - Common Stock (IMVT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunovant, Inc. - Common Stock stock?
Investing in Immunovant, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMVT chart and related analysis on metatrader.com as part of your research.